The magic and mystery of MicroRNA-27 in atherosclerosis

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 314-323

  Chen, Wu Jun ^a   Yin, Kai ^a   Zhao, Guo Jun ^a   Fu, Yu Chang ^b   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atherosclerosis; Inflammation; Lipid metabolism; MiR 27; Mystery

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD36 ANTIGEN; COLLAGENASE 3; CYTOCHROME P450 4A1; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FATTY ACID BINDING PROTEIN 4; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 27; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOCYTE; ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE PROTEINS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPID METABOLISM; MICRORNAS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84862782175     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.020     Document Type: Review

References (70)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Yin K., Liao D.F., Tang C.K. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol Med 2010, 16:438-449.
3. Weber C., Schober A., Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets 2010, 11:950-956.
4. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5'UTR as in the 3'UTR. Proc Natl Acad Sci USA 2007, 104:9667-9672.
5. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 2009, 69:3245-3248.
6. Fernandez-Hernando C., Suarez Y., Rayner K.J., et al. MicroRNAs in lipid metabolism. Curr Opin Lipidol 2011, 22:86-92.
7. Li T., Cao H., Zhuang J., et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 2011, 412:66-70.
8. Jennewein C., von Knethen A., Schmid T., et al. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 2010, 285:11846-11853.
9. Staszel T., Zapala B., Polus A., et al. Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 2011, 121:361-367.
10. Khurana R., Simons M., Martin J.F., et al. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005, 112:1813-1824.
11. Kuehbacher A., Urbich C., Zeiher A.M., et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007, 101:59-68.
12. Zhou Q., Gallagher R., Ufret-Vincenty R., et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc Natl Acad Sci USA 2011, 108:8287-8292.
13. - mice. Circ Res 2008, 103:1181-1189.
14. Moura R., Tjwa M., Vandervoort P., et al. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol 2007, 27:2163-2169.
15. Di Stefano R., Felice F. Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 2009, 15:1095-1096.
16. Weis S.M., Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504.
17. Celletti F.L., Waugh J.M., Amabile P.G., et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001, 7:425-429.
18. Verhagen S.N., Visseren F.L. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011, 214:3-10.
19. Lin Q., Gao Z., Alarcon R.M., Ye J., et al. A role of miR-27 in the regulation of adipogenesis. FEBS J 2009, 276:2348-2358.
20. Kim S.Y., Kim A.Y., Lee H.W., et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 2010, 392:323-328.
21. Karbiener M., Fischer C., Nowitsch S., et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009, 390:247-251.
22. Wang J., Song Y., Zhang Y., et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2011.
23. Ji J., Zhang J., Huang G., et al. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009, 583:759-766.
24. Herrera B.M., Lockstone H.E., Taylor J.M., et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010, 53:1099-1109.
25. Kanter J.E., Averill M.M., Leboeuf R.C., et al. Diabetes-accelerated atherosclerosis and inflammation. Circ Res 2008, 103:e116-e117.
26. Hasegawa H., Takano H., Komuro I. Therapeutic implications of PPARgamma in cardiovascular diseases. PPAR Res 2010, 2010.
27. Lefterova M.I., Zhang Y., Steger D.J., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008, 22:2941-2952.
28. Moschos S.A., Williams A.E., Perry M.M., et al. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 2007, 8:240.
29. Kida K., Nakajima M., Mohri T., et al. PPARalpha is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011, 28:2467-2476.
30. Chhabra R., Adlakha Y.K., Hariharan M., et al. Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS One 2009, 4:e5848.
31. Bowen-Pope D.F., Schaub F.J. Apoptosis of smooth muscle cells is not silent: Fas/FADD initiates a program of inflammatory gene expression. Trends Cardiovasc Med 2001, 11:42-45.
32. Culpan D., Kehoe P.G., Love S. Tumour necrosis factor-alpha (TNF-alpha) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-alpha on miRNA expression in vitro. Int J Mol Epidemiol Genet 2011, 2:156-162.
33. Akhtar N., Rasheed Z., Ramamurthy S., et al. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62:1361-1371.
34. Deguchi J.O., Aikawa E., Libby P., et al. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005, 112:2708-2715.
35. Prescott M.F., Sawyer W.K., Von Linden-Reed J., et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3 MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 1999, 878:179-190.
36. Zhou R., Hu G., Liu J., et al. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog 2009, 5:e1000681.
37. West A.P., Brodsky I.E., Rahner C., et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
38. Li M., Fukagawa N.K. Age-related changes in redox signaling and VSMC function. Antioxid Redox Signal 2010, 12:641-655.
39. *, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem 2011, 352:181-188.
40. Chintharlapalli S., Papineni S., Abdelrahim M., et al. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 2009, 125:1965-1974.
41. Jutooru I., Chadalapaka G., Abdelrahim M., et al. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol Pharmacol 2010, 78:226-236.
42. Pathi S.S., Jutooru I., Chadalapaka G., et al. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol Cancer Res 2011, 9:195-202.
43. Her G.M., Hsu C.C., Hong J.R., et al. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 2011, 1811:536-548.
44. Alisi A., Da Sacco L., Bruscalupi G., et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 2011, 91:283-293.
45. Chapman M.J., Ginsberg H.N., Amarenco P., et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011, 32:1345-1361.
46. Zhang X., Qi R., Xian X., et al. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res 2008, 102:250-256.
47. Tsutsumi K., Inoue Y., Shima A., et al. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest 1993, 92:411-417.
48. Zhang C., Yin W., Liao D., et al. NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs. J Lipid Res 2006, 47:2055-2063.
49. Hao X.R., Cao D.L., Hu Y.W., et al. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009, 203:417-428.
50. Hu Y.W., Ma X., Li X.X., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-e43.
51. Liu X.H., Xiao J., Mo Z.C., et al. Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells. J Cardiovasc Pharmacol 2010, 56:309-319.
52. Mo Z.C., Xiao J., Liu X.H., et al. AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent manner. J Atheroscler Thromb 2011, 18:796-797.
53. Chen W.J., Yin K., Zhao G.J., et al. microRNAs: a new mechanisms for regulation of lipid metabolism. Prog Biochem Biophys 2010, 38:781-790.
54. Nishi H., Ono K., Horie T., et al. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol 2011, 31:744-755.
55. Erion M.D., Cable E.E., Ito B.R., et al. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci USA 2007, 104:15490-15495.
56. Yin K., Deng X., Mo Z.C., et al. Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. J Biol Chem 2011, 286:13834-13845.
57. Murphy A.J., Woollard K.J., Suhartoyo A., et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 2011, 31:1333-1341.
58. Hu Y.W., Wang Q., Ma X., et al. TGF-beta1 up-regulates expression of ABCA1 ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. J Atheroscler Thromb 2010, 17:493-502.
59. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170.
60. Bolick D.T., Skaflen M.D., Johnson L.E., et al. G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ Res 2009, 104:318-327.
61. Parks B.W., Srivastava R., Yu S., et al. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2009, 29:539-547.
62. Murakami N., Hashidate T., Harayama T., et al. Transcriptional regulation of human G2A in monocytes/macrophages: involvement of c/EBPs Runx and Pu. 1. Genes Cells 2009, 14:1441-1455.
63. Feng J., Iwama A., Satake M., et al. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol 2009, 145:412-423.
64. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
65. Castoldi M., Vujic Spasic M., Altamura S., et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 2011, 121:1386-1396.
66. Rayner K.J., Suarez Y., Davalos A., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
67. Najafi-Shoushtari S.H., Kristo F., Li Y., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
68. Rayner K.J., Esau C.C., Hussain F.N., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478:404-407.
69. Ramirez C.M., Davalos A., Goedeke L., et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011, 31:2707-2714.
70. Xiang Y., Ma Y.T., Chen B.D., et al. Transfection of recombinant adeno-associated virus serotype 9 to mouse heart in vivo and the effects on cardiac function. Heart 2010, 96:A73.